EMA review of suicide risk for Ozempic, Saxenda extended to other GLP-1 receptor agonists | Biospace

Pictured: The EMA building at its old headquarters in London/iStock, Lubo Ivanko

Pictured: The EMA building at its old headquarters in London/iStock, Lubo Ivanko The European Medicines Agency has extended its review of a potential suicide risk associated with Novo Nordisk’s Ozempic and Saxenda to other GLP-1 receptor agonists used for weight loss and the treatment of type 2 diabetes. The review was initiated by the Icelandic … Read more

Biopharma Lawsuit Tracker 2023: Novo Nordisk, Gilead and Teva | Biospace

Gavel on the table

Pictured: a wooden gavel on a table with a book in the background/iStock, nathaphat Between the much-debated Inflation Reduction Act, tightening Federal Trade Commission regulation, and ongoing patent battles, legal news about biopharmaceuticals is abundant. Here, we present our new, exclusive Biopharma Lawsuit Tracker. Follow along as we keep you updated on who’s headed to … Read more

CAR-T Cell Study Enabled by 10x Genomics Single Cell Technology Published in Nature Medicine | Biospace

10x Genomics Logo (PRNewsfoto/10x Genomics, Inc.)

Data uncovers new gene signature to help understand persistence in CAR-T cells PLEASANTON, Calif., July 5, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single-cell and space biology, today announced that its single-cell genomic technologies are being used in a study published in the journal Medicine of Nature on new genetic signatures … Read more